Prevalence and risk factors for neuropathy in a Canadian First Nation community

被引:80
作者
Bruce, Sharon G. [1 ]
Young, T. Kue [2 ]
机构
[1] Univ Manitoba, Dept Community Hlth Serv, Winnipeg, MB, Canada
[2] Univ Toronto, Dept Publ Hlth Serv, Toronto, ON, Canada
关键词
D O I
10.2337/dc08-0278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of this study was to determine the prevalence of and risk factors for diabetic neuropathy in a Canadian First Nation population. RESEARCH DESIGN AND METHODS - This was a community-based screening study of 483 adults. Measures included glucose, A1C, cholesterol, triglycerides, homocysteine, hypertension, waist circumference, height, weight, and foot examinations. Neuropathy was defined as loss of protective sensation determined through application of a 10-g monofilament. RESULTS - Twenty-two percent of participants had a previous diagnosis of diabetes, and 14% had new diabetes or impaired fasting glucose (IFG). The prevalence of neuropathy increased by glucose level: 5% among those with normal glucose levels, 8% among those with new IFG and diabetes, and 15% among those with established diabetes (P < 0.01). Those with neuropathy were more likely to have foot deformities (P < 0.01) and callus (P < 0.001) than those without neuropathy. Among those with dysglycemia (>= 6.1 mmol/l), the mean number of foot problems for those with insensate feet was 3 compared with 0.3 among those with sensation (P < 0.001). In multivariate logistic regression female sex, low education, A1C, smoking, and homocysteine were independently associated with neuropathy, after controls for age. CONCLUSIONS - Neuropathy prevalence is high, given the young age of our participants (mean 40 years) and was present among those with undiagnosed diabetes. The high number and type of foot problems places this population at increased risk for ulceration; the low level of foot care in the community increases the risk. Homocysteine is a risk factor that may be related to lifestyle and requires further investigation.
引用
收藏
页码:1837 / 1841
页数:5
相关论文
共 28 条
[1]  
ALLISON MA, J AM COLL CARDIOL, V48, P1190
[2]   Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus [J].
Ambrosch, A ;
Dierkes, J ;
Lobmann, R ;
Kühne, W ;
König, W ;
Luley, C ;
Lehnert, H .
DIABETIC MEDICINE, 2001, 18 (03) :185-192
[3]   The 10-g monofilament - The diagnostic divining rod for the diabetic foot? [J].
Armstrong, DG .
DIABETES CARE, 2000, 23 (07) :887-887
[4]   Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration [J].
Armstrong, DG ;
Lavery, LA ;
Vela, SA ;
Quebedeaux, TL ;
Fleischli, JG .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (03) :289-292
[5]  
Armstrong DG, 2005, CLIN CARE DIABETIC F
[6]  
Boulton AJM, 2003, TXB DIABETIC NEUROPA, P295
[7]   A prospective study of risk factors for diabetic foot ulcer - The Seattle diabetic foot study [J].
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Davignon, DR ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1036-1042
[8]   Treatment for diabetic foot ulcers [J].
Cavanagh, PR ;
Lipsky, BA ;
Bradbury, AW ;
Botek, G .
LANCET, 2005, 366 (9498) :1725-1735
[9]   Foot abnormalities in Canadian Aboriginal adolescents with Type 2 diabetes [J].
Chuback, J. ;
Embil, J. M. ;
Sellers, E. ;
Trepman, E. ;
Cheang, M. ;
Dean, H. .
DIABETIC MEDICINE, 2007, 24 (07) :747-752
[10]  
*CSEP, 1996, CAN PHYS ACT FITN LI